About Elevexo®
Elevexo® Product Overview
Elevexo® is an FDA-compliant cosmetic Topical Product, ensuring safety and regulatory trust, designed to maximize the cell-signaling capabilities of exosomes, delivering the regenerative effects of amniotic fluid and Wharton’s Jelly via the FDA-cleared NanoPen®. A topical cosmetic with unadulterated Exosomes derived from pure amniotic fluid suspension and umbilical cord Wharton’s Jelly.
Averaging 70 billion protein particles carrying diverse exosome cargo such as miRNA, mRNA, proteins, lipids, growth factors, peptides, extracellular matrix components, collagens, and hyaluronic acid. Packaged in 5mL lyophilized vials, produced under cGMP and cGTP standards, with rigorous quality control systems and licensed across all relevant states to ensure consistent safety and quality.
Our Scientific Framework
Growth Factor Signaling
Precisely selected growth factors influence pathways related to cell renewal, angiogenesis, and extracellular matrix reinforcement all essential to skin and hair vitality.
Biomimetic Peptide Technology
Peptides modeled after natural biological messengers strengthen structural integrity, modulate inflammation, and enhance regenerative activity.
Microenvironment Optimization
Compounds such as hyaluronic acid, PDRN, and adenosine support hydration balance, vascular responsiveness, and tissue repair fundamentals.
Synergistic Formulation Design
Each ingredient is chosen not only for its individual effect but for its ability to reinforce complementary pathways involved in dermal and follicular health.
Designed for Clinical Integration
Elevexo works closely with medical professionals to align each formulation with real-world procedural workflows. Both EleveXo H and EleveXo S complement in-clinic regenerative modalities, offering providers a structured, science-driven addition to their treatment protocols.